These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29259218)

  • 21. Molecular analysis of the York antigen of the Knops blood group system.
    Veldhuisen B; Ligthart PC; Vidarsson G; Roels I; Folman CC; van der Schoot CE; de Haas M
    Transfusion; 2011 Jul; 51(7):1389-96. PubMed ID: 21214579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana.
    Hansson HH; Kurtzhals JA; Goka BQ; Rodriques OP; Nkrumah FN; Theander TG; Bygbjerg IC; Alifrangis M
    Malar J; 2013 Nov; 12():400. PubMed ID: 24200236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement receptor 1 red cell expression is not controlled by the In(Lu) gene.
    Moulds JM; Shah C
    Transfusion; 1999 Jul; 39(7):751-5. PubMed ID: 10413284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Near-field quantification of complement receptor 1 (CR1/CD35) protein clustering in human erythrocytes.
    Lapin ZJ; Höppener C; Gelbard HA; Novotny L
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):539-43. PubMed ID: 22374251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting.
    Petty AC; Green CA; Poole J; Daniels GL
    Transfus Med; 1997 Mar; 7(1):55-62. PubMed ID: 9089986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Johansson JU; Brubaker WD; Javitz H; Bergen AW; Nishita D; Trigunaite A; Crane A; Ceballos J; Mastroeni D; Tenner AJ; Sabbagh M; Rogers J
    Alzheimers Dement; 2018 Nov; 14(11):1438-1449. PubMed ID: 29792870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knops blood group haplotypes among distinct Brazilian populations.
    Covas DT; de Oliveira FS; Rodrigues ES; Abe-Sandes K; Silva WA; Fontes AM
    Transfusion; 2007 Jan; 47(1):147-53. PubMed ID: 17207243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polymorphism of Knops blood group system in Korean population and their relationship with HLA system.
    Yoon JH; Oh S; Shin S; Park JS; Roh EY; Song EY; Park MH; Han KS; Chang JY
    Hum Immunol; 2013 Feb; 74(2):196-8. PubMed ID: 23127551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.
    Cockburn IA; Rowe JA
    Int J Immunogenet; 2006 Feb; 33(1):17-20. PubMed ID: 16426237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographical distribution of complement receptor type 1 variants and their associated disease risk.
    Lucas Sandri T; Adukpo S; Giang DP; Nguetse CN; Antunes Andrade F; Tong HV; Toan NL; Song LH; Elumalai P; Thangaraj K; Valluri VL; Ntoumi F; Meyer CG; Jose de Messias Reason I; Kremsner PG; Velavan TP
    PLoS One; 2017; 12(5):e0175973. PubMed ID: 28520715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The polymorphism of the Knops blood group system among five Chinese ethnic groups.
    Li Q; Han SS; Guo ZH; Yang Y; Zhou J; Zhu ZY
    Transfus Med; 2010 Dec; 20(6):369-75. PubMed ID: 20670356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1.
    Ghiran I; Glodek AM; Weaver G; Klickstein LB; Nicholson-Weller A
    Blood; 2008 Oct; 112(8):3465-73. PubMed ID: 18684861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.
    Wang FS; Chu FL; Jin L; Li YG; Zhang Z; Xu D; Shi M; Wu H; Moulds JM
    Clin Exp Immunol; 2005 Jan; 139(1):112-9. PubMed ID: 15606620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
    Paccaud JP; Carpentier JL; Schifferli JA
    J Immunol; 1988 Dec; 141(11):3889-94. PubMed ID: 2972779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.